Industrial Alliance Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Industrial Alliance Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-700	Closed	-$246K	–	161
2023 Q2	$246K	Sell	700 -40,532	-98%	-$13.7M	0.13%	70
2023 Q1	$13M	Sell	41,232 -8,957	-18%	-$2.69M	0.36%	62
2022 Q4	$14.5M	Sell	50,189 -12,559	-20%	-$3.83M	0.4%	60
2022 Q3	$18.2M	Buy	62,748 +13,413	+27%	+$3.86M	0.53%	44
2022 Q2	$13.9M	Buy	49,335 +6,333	+15%	+$1.7M	0.4%	65
2022 Q1	$11.2M	Sell	43,002 -4,630	-10%	-$1.1M	0.27%	91
2021 Q4	$10.5M	Buy	+47,632	New	+$9.26M	0.24%	99

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Industrial Alliance Investment Management's VRTX Position: Q3 2023 in Review

Industrial Alliance Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 700 shares — an estimated $246K sold.

Industrial Alliance Investment Management first reported a position in VRTX in Q4 2021 and held it in 7 quarters. The position peaked at $18.2M in Q3 2022. 1,278 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

Industrial Alliance Investment Management reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Industrial Alliance Investment Management sold 700 Vertex Pharmaceuticals shares in Q3 2023, an estimated $246K.
Industrial Alliance Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Industrial Alliance Investment Management's Vertex Pharmaceuticals position peaked at $18.2M in Q3 2022.
1,278 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q3 2023, filed 15 Nov 2023.